The Epidermolysis Bullosa Disease Activity and Scarring Index (EBDASI): grading disease severity and assessing responsiveness to clinical change in epidermolysis bullosa-Reference-Cited by-同舟云学术

The Epidermolysis Bullosa Disease Activity and Scarring Index (EBDASI): grading disease severity and assessing responsiveness to clinical change in epidermolysis bullosa

Published:2016-10-03 Issue:4 Volume:31 Page:692-698
ISSN:0926-9959
Container-title:Journal of the European Academy of Dermatology and Venereology
language:en
Short-container-title:J Eur Acad Dermatol Venereol

Author:

Jain S.V.¹²,Harris A.G.¹²,Su J.C.³⁴,Orchard D.³⁴,Warren L.J.⁵,McManus H.⁶,Murrell D.F.¹²

Affiliation:

1. Department of Dermatology; St George Hospital; Sydney NSW Australia

2. Faculty of Medicine; University of New South Wales; Sydney NSW Australia

3. Department of Dermatology; The Royal Children's Hospital; Melbourne Vic. Australia

4. Department of Paediatrics; University of Melbourne; Melbourne Vic. Australia

5. Department of Dermatology; Women's and Children's Hospital; Adelaide SA Australia

6. Kirby Institute; University of New South Wales; Sydney NSW Australia

Funder

University of New South Wales Medicine Honours Research Program

University of New South Wales Honours Research Scholarship

Australasian Blistering Diseases Foundation

The Caroline Quinn Trust

Premier Dermatology

Publisher

Wiley

Subject

Infectious Diseases,Dermatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jdv.13953/fullpdf

Reference21 articles.

1. Japanese guidelines for diagnosis and treatment of junctional and dystrophic epidermolysis bullosa;Tamai;Arch Dermatol Res,2003

2. The Birmingham Epidermolysis Bullosa Severity score: development and validation;Moss;Br J Dermatol,2009

3. Instrument for scoring clinical outcome of research for epidermolysis bullosa: a consensus-generated clinical research tool;Schwieger-Briel;Pediatr Dermatol,2015

4. Development, reliability, and validity of a novel Epidermolysis Bullosa Disease Activity and Scarring Index (EBDASI);Loh;J Am Acad Dermatol,2014

5. Reliability and convergent validity of two outcome instruments for pemphigus;Rosenbach;J Invest Dermatol,2009

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Establishing minimal clinically important differences for the Pemphigus Disease Area Index;British Journal of Dermatology;2024-07-13

2. Psychometric Properties of the Instrument for Scoring Clinical Outcomes of Research for Epidermolysis Bullosa patient score (iscorEB-p): a patient-reported outcome measure;British Journal of Dermatology;2024-01-23

3. Oleogel-S10 in Dystrophic Epidermolysis Bullosa: A Case Series Evaluating the Impact on Wound Burden Over Two Years;Advances in Therapy;2024-01-03

4. Precision in treatment evaluation: importance of minimal clinically important differences (MCIDs) of outcome measures for autoimmune blistering diseases;Frontiers in Immunology;2023-09-25

5. Birch Bark Extract: A Review in Epidermolysis Bullosa;Drugs;2023-09